These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 7071809)

  • 1. Progressive antithrombin activity and the concentration of three thrombin inhibitors in liver cirrhosis.
    Boneu B; Sie P; Caranobe C; Cassigneul J; Pascal J
    Thromb Haemost; 1982 Feb; 47(1):78. PubMed ID: 7071809
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in nephrotic syndrome.
    Boneu B; Bouissou F; Abbal M; Sie P; Caranobe C; Barthe P
    Thromb Haemost; 1981 Oct; 46(3):623-5. PubMed ID: 6171906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian rhythms of fibrinogen and antithrombin III in liver cirrhosis.
    Pasqualetti P; Casale R
    Riv Eur Sci Med Farmacol; 1995; 17(4):125-9. PubMed ID: 8545565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the thrombin time in cirrhosis.
    Braunstein KM; Kinard HB; Hepfer TW; Craig WR; Eurenius K
    Thromb Res; 1976 Oct; 9(4):301-17. PubMed ID: 136058
    [No Abstract]   [Full Text] [Related]  

  • 5. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
    Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
    Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemostatic abnormalities in patients with liver disease associated with viral hepatitis.
    Pramoolsinsap C; Busagorn N; Kurathong S
    J Med Assoc Thai; 1996 Nov; 79(11):681-8. PubMed ID: 8997005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
    Kudriashov BA; Pastorova VE; Liapina LA
    Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the prethrombotic state in pregnancy and in women using oral contraceptives.
    Levine AB; Teppa J; McGough B; Cowchock FS
    Contraception; 1996 May; 53(5):255-7. PubMed ID: 8724613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombogenicity of the injured vessel wall--role of antithrombin and heparin.
    Frebelius S; Hedin U; Swedenborg J
    Thromb Haemost; 1994 Jan; 71(1):147-53. PubMed ID: 8165634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antithrombin III versus prothrombin in liver cirrhosis.
    Aurousseau MH; d'Angeli JL; Josso F
    Haemostasis; 1981; 10(2):104-7. PubMed ID: 7461504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin-based antithrombin assays show overestimation of antithrombin III activity in patients on heparin therapy due to heparin cofactor II influence.
    Bohner J; von Pape KW; Blaurock M
    Thromb Haemost; 1994 Mar; 71(3):280-3. PubMed ID: 8029789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of progressive antithrombin activity and the concentration of three thrombin inhibitors in human plasma.
    Abildgaard U; Fagerhol MK; Egeberg O
    Scand J Clin Lab Invest; 1970 Dec; 26(4):349-54. PubMed ID: 4098730
    [No Abstract]   [Full Text] [Related]  

  • 13. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma antithrombin III level in hyperlipidemic subjects.
    Cucuianu MP; Cristea A; Roman S; Missits I
    Clin Chim Acta; 1981 Mar; 110(2-3):147-55. PubMed ID: 7226527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo.
    Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT
    Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative value of prothrombin time and antithrombin III determinations in the diagnosis of liver cirrhosis].
    Monreal M; Monasterio J; Rodríguez R; García L; Rey-Joly C; Foz M
    Med Clin (Barc); 1984 Feb; 82(7):298-300. PubMed ID: 6717134
    [No Abstract]   [Full Text] [Related]  

  • 17. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
    Tran TH; Bondeli C; Marbet GA; Duckert F
    Thromb Haemost; 1980 Oct; 44(2):92-5. PubMed ID: 7455997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin III. Key factor in extracorporeal circulation.
    Ranucci M
    Minerva Anestesiol; 2002 May; 68(5):454-7. PubMed ID: 12029263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombin III deficiency.
    Cucuianu M; Blaga S; Pop S; Olinic D; Olinic N; Colhon D; Cristea A
    Rom J Intern Med; 1994; 32(2):119-27. PubMed ID: 7920326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Automated simultaneous measurements of activity and antigenicity of plasma antithrombin III].
    Tsushima C; Chiba H; Akizawa K; Araki K; Matsuno K; Kobayashi K
    Rinsho Byori; 1994 Jul; 42(7):713-7. PubMed ID: 8065037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.